Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe
Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Fulvestrant Injection
Zydus Cadila receives final approval from US FDA for Fulvestrant injection
The drug will be manufactured at the group’s formulation manufacturing facility at Zydus Biologics, Ahmedabad
Dr Reddy’s Laboratories launches Fulvestrant Injection in US
Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer
Glenmark receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)
A generic version of Faslodex Injection, 250 mg/5 mL (50 mg/mL), of AstraZeneca Pharmaceuticals